{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:42:33Z","timestamp":1770907353444,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00381-022-05489-5","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T05:02:35Z","timestamp":1646802155000},"page":"1077-1084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The neurosurgical management of Severe Hemophilia A and Moyamoya (SHAM): challenges, strategies, and literature review"],"prefix":"10.1007","volume":"38","author":[{"given":"Risheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita L.","family":"Kalluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney E.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujatha","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-501X","authenticated-orcid":false,"given":"Alan R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"5489_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A (1969) Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288\u2013299","journal-title":"Arch Neurol"},{"key":"5489_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the P, Treatment of spontaneous occlusion of the circle of W, Health Labour Sciences Research Grant for Research on Measures for Infractable D","year":"2012","unstructured":"Research Committee on the P, Treatment of spontaneous occlusion of the circle of W, Health Labour Sciences Research Grant for Research on Measures for Infractable D (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52:245\u2013266","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"5489_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2176\/nmc.ra.2014-0307","volume":"55","author":"M Fujimura","year":"2015","unstructured":"Fujimura M, Tominaga T (2015) Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo) 55:189\u2013193","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"5489_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","volume":"39","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42\u201347","journal-title":"Stroke"},{"key":"5489_CR5","first-page":"229","volume":"70","author":"T Hishikawa","year":"2016","unstructured":"Hishikawa T, Sugiu K, Date I (2016) Moyamoya disease: a review of clinical research. Acta Med Okayama 70:229\u2013236","journal-title":"Acta Med Okayama"},{"key":"5489_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS (2016) Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke 18:2\u201311","journal-title":"J Stroke"},{"key":"5489_CR7","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S (2008) Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900\u2013904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5489_CR8","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/STROKEAHA.113.004273","volume":"45","author":"IM Ahn","year":"2014","unstructured":"Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS (2014) Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke 45:1090\u20131095","journal-title":"Stroke"},{"key":"5489_CR9","doi-asserted-by":"crossref","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6:e22542","DOI":"10.1371\/journal.pone.0022542"},{"key":"5489_CR10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajhg.2011.04.017","volume":"88","author":"S Miskinyte","year":"2011","unstructured":"Miskinyte S, Butler MG, Herve D, Sarret C, Nicolino M, Petralia JD, Bergametti F, Arnould M, Pham VN, Gore AV, Spengos K, Gazal S, Woimant F, Steinberg GK, Weinstein BM, Tournier-Lasserve E (2011) Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 88:718\u2013728","journal-title":"Am J Hum Genet"},{"key":"5489_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaneurol.2021.1681","volume":"78","author":"AJ Kundishora","year":"2021","unstructured":"Kundishora AJ, Peters ST, Pinard A, Duran D, Panchagnula S, Barak T, Miyagishima DF, Dong W, Smith H, Ocken J, Dunbar A, Nelson-Williams C, Haider S, Walker RL, Li B, Zhao H, Thumkeo D, Marlier A, Duy PQ, Diab NS, Reeves BC, Robert SM, Sujijantarat N, Stratman AN, Chen YH, Zhao S, Roszko I, Lu Q, Zhang B, Mane S, Castaldi C, Lopez-Giraldez F, Knight JR, Bamshad MJ, Nickerson DA, Geschwind DH, Chen SL, Storm PB, Diluna ML, Matouk CC, Orbach DB, Alper SL, Smith ER, Lifton RP, Gunel M, Milewicz DM, Jin SC, Kahle KT (2021) DIAPH1 variants in non-East Asian patients with sporadic moyamoya disease. JAMA Neurol 78:993\u20131003","journal-title":"JAMA Neurol"},{"key":"5489_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2516.2007.01639.x","volume":"14","author":"PC Winter","year":"2008","unstructured":"Winter PC, Egan H, McNulty O, Jones FG, O\u2019Donnell J, Jenkins PV (2008) A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect. Haemophilia 14:394\u2013395","journal-title":"Haemophilia"},{"key":"5489_CR13","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1182\/blood-2014-02-553685","volume":"123","author":"S Janczar","year":"2014","unstructured":"Janczar S, Fogtman A, Koblowska M, Baranska D, Pastorczak A, Wegner O, Kostrzewska M, Laguna P, Borowiec M, Mlynarski W (2014) Novel severe hemophilia A and moyamoya (SHAM) syndrome caused by Xq28 deletions encompassing F8 and BRCC3 genes. Blood 123:4002\u20134004","journal-title":"Blood"},{"key":"5489_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000048372","volume":"36","author":"M Matsuda","year":"2002","unstructured":"Matsuda M, Enomoto T, Yanaka K, Nose T (2002) Moyamoya disease associated with hemophilia A. Case report Pediatr Neurosurg 36:157\u2013160","journal-title":"Case report Pediatr Neurosurg"},{"key":"5489_CR15","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1111\/hae.12806","volume":"22","author":"M Lavin","year":"2016","unstructured":"Lavin M, Jenkins PV, Keenan C, White B, Betts DR, O\u2019Donnell JS, O\u2019Connell NM (2016) X-linked moyamoya syndrome associated with severe haemophilia A. Haemophilia 22:e51-54","journal-title":"Haemophilia"},{"key":"5489_CR16","unstructured":"Bilancia CG, Varma H, Aggarwal V (2016) A new case of severe hemophilia and Moyamoya (SHAM) syndrome. CAP TODAY 1\u20133"},{"key":"5489_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12098-016-2229-5","volume":"84","author":"AG Saini","year":"2017","unstructured":"Saini AG, Goswami JN, Suthar R, Sankhyan N, Vyas S, Singhi P (2017) Probable Moyamoya syndrome in association with hemophilia A in an infant. Indian J Pediatr 84:164\u2013165","journal-title":"Indian J Pediatr"},{"key":"5489_CR18","doi-asserted-by":"crossref","unstructured":"Roh D, Roth W, Al-Mufti F, Chung W, Sander CE, Eisenberger A, Park S, Claassen J, Agarwal S (2016) The utility of factor VIII infusion in a rare case of SHAM syndrome (P4. 343). AAN Enterprises","DOI":"10.1212\/WNL.86.16_supplement.P4.343"},{"key":"5489_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","volume":"7","author":"E Berntorp","year":"2021","unstructured":"Berntorp E, Fischer K, Hart DP, Mancuso ME, Stephensen D, Shapiro AD, Blanchette V (2021) Haemophilia Nat Rev Dis Primers 7:45","journal-title":"Haemophilia Nat Rev Dis Primers"},{"key":"5489_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/hae.13998","volume":"26","author":"JM Soucie","year":"2020","unstructured":"Soucie JM, Miller CH, Dupervil B, Le B, Buckner TW (2020) Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres. Haemophilia 26:487\u2013493","journal-title":"Haemophilia"},{"key":"5489_CR21","first-page":"479","volume":"17","author":"L Aledort","year":"2019","unstructured":"Aledort L, Mannucci PM, Schramm W, Tarantino M (2019) Factor VIII replacement is still the standard of care in haemophilia A. Blood Transfus 17:479\u2013486","journal-title":"Blood Transfus"},{"key":"5489_CR22","doi-asserted-by":"crossref","unstructured":"Ma AD, Carrizosa D (2006) Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 432\u2013437","DOI":"10.1182\/asheducation-2006.1.432"},{"issue":"Suppl 1","key":"5489_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1365-2516.2000.00045.x","volume":"6","author":"DM DiMichele","year":"2000","unstructured":"DiMichele DM (2000) Inhibitors in haemophilia: a primer. Haemophilia 6(Suppl 1):38\u201340","journal-title":"Haemophilia"},{"key":"5489_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s40265-019-01200-2","volume":"79","author":"HA Blair","year":"2019","unstructured":"Blair HA (2019) Emicizumab: a review in haemophilia A. Drugs 79:1697\u20131707","journal-title":"Drugs"},{"key":"5489_CR25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1160\/TH17-01-0030","volume":"117","author":"T Kitazawa","year":"2017","unstructured":"Kitazawa T, Esaki K, Tachibana T, Ishii S, Soeda T, Muto A, Kawabe Y, Igawa T, Tsunoda H, Nogami K, Shima M, Hattori K (2017) Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX\/IXa and X\/Xa, emicizumab, depends on its ability to bridge the antigens. Thromb Haemost 117:1348\u20131357","journal-title":"Thromb Haemost"},{"key":"5489_CR26","first-page":"44","volume":"42","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Ren GM, Zhan YQ, Miao Y, CY LI, Yang XM, Yin RH (2018) Construction of BRCC3 gene knockout mice and preliminary analysis of the pheno-type. Mil Med Sci 42:44\u201348","journal-title":"Military Medical Sciences"},{"key":"5489_CR27","unstructured":"Yelton SEG, Williams MA, Young M, Fields J, Pearl MS, Casella JF, Lawrence CE, Felling RJ, Jackson EM, Robertson C (2021) Perioperative management of pediatric patients with moyamoya arteriopathy. J Pediatr Intensive Care"},{"key":"5489_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3171\/2014.1.JNS13946","volume":"121","author":"K Kazumata","year":"2014","unstructured":"Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H (2014) The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg 121:432\u2013440","journal-title":"J Neurosurg"},{"key":"5489_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Bang JS, Kim JE, Cho WS (2016) Moyamoya disease: treatment and outcomes. J Stroke 18:21\u201330","journal-title":"J Stroke"},{"key":"5489_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000369524","volume":"39","author":"XY Bao","year":"2015","unstructured":"Bao XY, Duan L, Yang WZ, Li DS, Sun WJ, Zhang ZS, Zong R, Han C (2015) Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China. Cerebrovasc Dis 39:75\u201381","journal-title":"Cerebrovasc Dis"},{"key":"5489_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/hae.14212","volume":"27","author":"M Lewandowska","year":"2021","unstructured":"Lewandowska M, Randall N, Bakeer N, Maahs J, Sagar J, Greist A, Shapiro AD (2021) Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: real-world experience from a large comprehensive treatment centre in the US. Haemophilia 27:90\u201399","journal-title":"Haemophilia"},{"key":"5489_CR32","doi-asserted-by":"crossref","unstructured":"Hartmann R, Feenstra T, Valentino L, Dockal M, Scheiflinger F (2018) In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents. J Thromb Haemost","DOI":"10.1111\/jth.14203"},{"key":"5489_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1055\/s-0029-1245106","volume":"35","author":"NM Ananyeva","year":"2009","unstructured":"Ananyeva NM, Lee TK, Jain N, Shima M, Saenko EL (2009) Inhibitors in hemophilia A: advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents. Semin Thromb Hemost 35:735\u2013751","journal-title":"Semin Thromb Hemost"},{"key":"5489_CR34","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","volume":"104","author":"HR Roberts","year":"2004","unstructured":"Roberts HR, Monroe DM, White GC (2004) The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104:3858\u20133864","journal-title":"Blood"},{"key":"5489_CR35","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/jth.14491","volume":"17","author":"GG Levy","year":"2019","unstructured":"Levy GG, Asikanius E, Kuebler P, Benchikh El Fegoun S, Esbjerg S, Seremetis S (2019) Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: experience from the HAVEN clinical program. J Thromb Haemost 17:1470\u20131477","journal-title":"J Thromb Haemost"},{"key":"5489_CR36","doi-asserted-by":"crossref","unstructured":"Li Y, Wang J (2019) Efficacy of aminocaproic acid in the control of bleeding after total knee and hip arthroplasty: a systematic review and meta-analysis. Medicine (Baltimore) 98:e14764","DOI":"10.1097\/MD.0000000000014764"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-022-05489-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-022-05489-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-022-05489-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T23:23:57Z","timestamp":1726788237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-022-05489-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5489"],"URL":"https:\/\/doi.org\/10.1007\/s00381-022-05489-5","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}